MetaCap

MDxHealth SA (MDXH) vs XWELL (XWEL)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.

Summary

MDxHealth SA is the larger company by market cap ($56.3 million vs $8.2 million), about 6.9 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

MDXH-1.68%XWEL-8.92%
+2%-4%-9%
Oct 7, 20261 yearOct 9, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

MDXH versus XWEL key metrics
MetricMDXHXWEL
Share price$0.5897$0.8215
Market cap$56.27M$8.19M
1-day change+1.58%-10.60%
YTD return-83.48%—
1-year return-86.47%—
EPS (TTM)$-0.70$-4.68
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$5.33$2.20
52-week low$0.40$0.26
Distance from 52-week high-88.94%-62.66%
Analyst consensusnone—
Avg. price target upside+205.24%—
Average volume5.78M35.96K
Shares outstanding95.42M9.97M
Employees364175
SectorHealth CareConsumer Discretionary
IndustryMedical SpecialitiesOther Consumer Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • MDxHealth SA is about 6.9 times larger than XWELL by market value ($56.27M vs $8.19M).
  • The two companies sit in different sectors: MDxHealth SA in Health Care and XWELL in Consumer Discretionary.

About MDxHealth SA

MDXH stock →

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; ExoD, a non-invasive urine test to assess risk of having clinically prostate cancer; and Resolve mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection.

Health Care · Medical Specialities · 364 employees

About XWELL

XWEL stock →

XWELL, Inc. engages in the provision of health and wellness services to travelers in the United States and internationally.

Consumer Discretionary · Other Consumer Services · 175 employees

MDXH vs XWEL FAQ

Which is bigger, MDxHealth SA or XWELL?

MDxHealth SA (MDXH) is larger, with a market capitalization of $56.27M compared with $8.19M for XWELL (XWEL).

Are MDxHealth SA and XWELL in the same industry?

No. MDxHealth SA is in the Health Care sector, while XWELL is in Consumer Discretionary.

More comparisons